Next Article in Journal
Proceedings of the Online Conference “Vaccines and Vaccination during and Post COVID Pandemics” (7–9 December 2022)
Next Article in Special Issue
The Limitations of Current T Cell-Driven Anticancer Immunotherapies Can Be Overcome with an Original Extracellular-Vesicle-Based Vaccine Strategy
Previous Article in Journal
Humoral Immune Response of Mice against a Vaccine Candidate Composed of a Chimera of gB of Bovine Alphaherpesviruses 1 and 5
Previous Article in Special Issue
Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study
 
 
Article

Article Versions Notes

Vaccines 2023, 11(7), 1174; https://doi.org/10.3390/vaccines11071174
Action Date Notes Link
article xml file uploaded 29 June 2023 08:43 CEST Original file -
article xml uploaded. 29 June 2023 08:43 CEST Update -
article pdf uploaded. 29 June 2023 08:43 CEST Version of Record https://www.mdpi.com/2076-393X/11/7/1174/pdf-vor
article supplementary file uploaded. 29 June 2023 08:43 CEST - https://www.mdpi.com/2076-393X/11/7/1174#supplementary
article html file updated 29 June 2023 08:45 CEST Original file -
article html file updated 29 June 2023 08:46 CEST Update -
article html file updated 29 June 2023 08:47 CEST Update -
article html file updated 6 July 2023 22:56 CEST Update -
article xml file uploaded 25 July 2023 09:22 CEST Update -
article xml uploaded. 25 July 2023 09:22 CEST Update https://www.mdpi.com/2076-393X/11/7/1174/xml
article pdf uploaded. 25 July 2023 09:22 CEST Updated version of record https://www.mdpi.com/2076-393X/11/7/1174/pdf
article html file updated 25 July 2023 09:24 CEST Update https://www.mdpi.com/2076-393X/11/7/1174/html
Back to TopTop